A 16-year-old with sickle cell disease arrived at a Cincinnati emergency department with a three-day headache and lower back pain. A CT scan of his head showed no acute findings. His headache eased; he was treated for a pain crisis and sent home.
Three days later, he was back, and his face was swelling.
The case, published August 24 in Emergency Radiology by radiologists and hematologists at Cincinnati Children's Hospital Medical Center and the University of Cincinnati, documents acute soft head syndrome, a complication so uncommon that most of what physicians know about it comes from individual case descriptions.
The Scan That Changed the Picture
On his return, the teenager's headache had worsened, and swelling had appeared around his left eye. Laboratory work showed his hemoglobin had dropped to 6.9 grams per deciliter from a baseline of 9.0, with markers of ongoing red blood cell destruction and elevated inflammation.
Because the craniofacial swelling was progressing, doctors ordered an MRI the same day. It showed multiple areas of infarction in the calvarium, the domed part of the skull, meaning patches of bone had lost their blood supply and died. Sitting above those patches were collections of blood between the bone and its outer membrane, plus diffuse fluid throughout the scalp tissue.
The teenager's history reads like a catalog of what sickle cell disease can do over time: avascular necrosis of the right hip requiring a total hip replacement at age 10, acute chest syndrome, splenic sequestration. He had been taking hydroxyurea since early childhood.
How MRI Ruled Out an Infection
Scalp swelling with fever in a teenager usually points somewhere else entirely. Osteomyelitis, a bone infection, and orbital cellulitis both sit high on that list, and both are treated very differently from a sickling event.
The distinguishing evidence came from diffusion-weighted imaging. Pus restricts the movement of water molecules, producing a characteristic signal. The collections in this patient did not show that pattern. Susceptibility-weighted imaging instead picked up scattered foci consistent with blood products. There was no cortical destruction, no abscess, and no evidence of orbital infection.
The clinical picture agreed. Blood cultures, drawn because he had a low-grade fever, came back negative. He received a single precautionary dose of ceftriaxone because functional loss of the spleen raises the risk of bacteremia in sickle cell disease, but no full antibiotic course was followed.
Treatment was supportive: intravenous pain control, hydration, continued hydroxyurea, and two packed red blood cell transfusions. His hemoglobin climbed from 6.9 to 10.8 within 48 hours. He went home after two days and remained symptom-free through seven months of follow-up.
Rare, and Not Always Benign
The authors cite a 2024 systematic review in the Journal of Child Neurology that included 16 reported pediatric cases of skull infarction in sickle cell disease. In that pooled group, epidural hematoma occurred in 11 of the 16 patients, and roughly 30% required surgical drainage.
This patient had no epidural bleeding, which is part of why conservative management worked. In the absence of epidural hemorrhage, the authors write, standard vaso-occlusive crisis care is reasonable, while severe cases with intracranial involvement may require exchange transfusion.
The proposed mechanism remains unproven. Chronic marrow expansion in the skull, driven by the body's constant demand for new red blood cells, may thin and weaken the bone. Microfractures in that fragile bone could then let blood leak into the spaces beneath the scalp. The authors describe this as a hypothesis needing further investigation.
Most reported cases have involved peripubertal or adolescent males with the HbSS genotype, the most severe form of the disease, and the pattern this patient fits. Why that group appears disproportionately in the literature remains unclear.
Why the First Normal Scan Matters Most
The report's sharpest practical point concerns that initial CT. Early calvarial infarction can be radiographically invisible, and the authors warn that a negative CT should not reassure clinicians when suspicion stays high or symptoms worsen.
That warning lands in a population already fighting to be believed. The Centers for Disease Control and Prevention estimates sickle cell disease affects about 100,000 people in the United States, more than 90% of whom are non-Hispanic Black or African American, with life expectancy more than 20 years shorter than average. The agency notes that many patients have difficulty accessing appropriate care and report feeling stigmatized and having their symptoms dismissed when they seek it.
Treatment options have expanded. In July, the Food and Drug Administration approved the gene therapy Casgevy for patients as young as 2 with recurrent vaso-occlusive crises, extending a label previously limited to those 12 and older.
None of that changes what happens in an emergency department at 2 a.m. This is a single case report, and it cannot establish how often acute soft head syndrome occurs or how it should be managed across patients. What it offers is a pattern to recognize: a new or worsening headache with progressive scalp or facial swelling during a sickle cell pain crisis, and imaging that may need to be repeated before it shows anything.
Key Questions Answered
What is acute soft head syndrome?
It is a rare complication of sickle cell disease in which scalp swelling develops without trauma, caused by infarction of the skull bones and by bleeding or fluid collecting in the layers above them.
How common is it?
Extremely uncommon. A systematic review published in 2024 identified only 16 reported pediatric cases of skull infarction in sickle cell disease, and the authors of this case describe the syndrome as underrecognized, with limited collective experience in the literature.
Why was infection the main alternative diagnosis?
Scalp and periorbital swelling with fever and elevated inflammatory markers strongly suggest bone infection or orbital cellulitis. Telling them apart matters because those conditions require antibiotics and sometimes surgery.
How did doctors tell the difference?
Specialized MRI sequences. Abscesses restrict water diffusion in a recognizable way, and these collections did not. Imaging also showed blood products rather than pus, with no bone destruction. Negative blood cultures and rapid recovery without antibiotics supported the conclusion.
Should people with sickle cell disease worry about this?
The authors emphasize it is extremely rare, not a typical feature of the disease. The takeaway is aimed primarily at clinicians: keep it in mind when someone with sickle cell disease develops a new headache accompanied by head or facial swelling.
Does an initial normal CT scan rule it out?
Not necessarily. In this patient, the first CT showed no acute abnormality, and MRI three days later revealed multiple infarcts. The authors specifically caution against treating an early negative CT as reassurance.
